Trials / Completed
CompletedNCT06514963
A Trial of HRS-9813 in Healthy Volunteers
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect on the Pharmacokinetics of HRS-9813 Tablets After Single and Multiple Ascending Oral Doses in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this phase Ⅰ study is to evaluate the safety, tolerability and pharmacokinetics of HRS-9813 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-9813 | Specified dose on specified days |
| DRUG | Placebo | Specified dose on specified days |
Timeline
- Start date
- 2024-07-24
- Primary completion
- 2025-01-02
- Completion
- 2025-01-02
- First posted
- 2024-07-23
- Last updated
- 2025-01-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06514963. Inclusion in this directory is not an endorsement.